Danaher Corporation cash flow statement
In fiscal 2025, Danaher Corporation's operations generated $6.42bn of cash; it spent $1.16bn on capital projects, leaving free cash flow of $5.26bn. It returned $878m in dividends and $3.09bn through buybacks.
Cash flow statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,801 | 2,084 | 2,626 | 3,415 | 3,585 | 3,758 | 3,802 | 3,522 | 3,478 | 4,022 | 3,952 | 6,208 | 8,358 | 8,519 | 7,164 | 6,688 | 6,416 | 6,859 |
| Depreciation and amortisation | 332 | 388 | 635 | 840 | 851 | 718 | 881 | 1,128 | 1,117 | 1,178 | 1,189 | 1,775 | 2,062 | 2,132 | 2,166 | 721 | 750 | 792 |
| Stock-based pay | 87 | 88 | 96 | 110 | 110 | 85 | 104 | 130 | 127 | 138 | 159 | 187 | 184 | 295 | 306 | 288 | 298 | 329 |
| Capital spending | 175 | 191 | 335 | 458 | 538 | 465 | 513 | 590 | 571 | 584 | 636 | 791 | 1,240 | 1,118 | 1,383 | 1,392 | 1,156 | 1,132 |
| Free cash flow | 1,625 | 1,893 | 2,292 | 2,957 | 3,047 | 3,293 | 3,289 | 2,932 | 2,907 | 3,438 | 3,316 | 5,417 | 7,118 | 7,401 | 5,781 | 5,296 | 5,260 | 5,727 |
| Free cash flow after stock pay | 1,538 | 1,805 | 2,196 | 2,847 | 2,938 | 3,208 | 3,185 | 2,802 | 2,780 | 3,300 | 3,157 | 5,230 | 6,934 | 7,106 | 5,475 | 5,008 | 4,962 | 5,398 |
| Dividends paid | 42 | 52 | 61 | 86 | 52 | 228 | 354 | 400 | 378 | 433 | 527 | 615 | 742 | 818 | 821 | 768 | 878 | 1,016 |
| Share buybacks | 0 | — | 0 | 648 | 0 | 0 | — | — | — | — | — | — | — | 0 | 0 | 5,979 | 3,088 | 894 |
| Shares issued | 174 | 178 | 1,113 | 212 | 177 | 133 | 249 | 165 | 0 | 0 | 1,443 | 1,729 | 0 | 0 | — | — | — | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2,019 | 1,299 | 1,338 | 1,662 | 2,117 | 1,322 | 1,534 | 1,886 |
| Depreciation and amortisation | 187 | 181 | 185 | 189 | 195 | 193 | 196 | 208 |
| Stock-based pay | 57 | 61 | 91 | 83 | 63 | 58 | 93 | 115 |
| Capital spending | 516 | 245 | 248 | 292 | 371 | 237 | 269 | 255 |
| Free cash flow | 1,503 | 1,054 | 1,090 | 1,370 | 1,746 | 1,085 | 1,265 | 1,631 |
| Free cash flow after stock pay | 1,446 | 993 | 999 | 1,287 | 1,683 | 1,027 | 1,172 | 1,516 |
Compare with peers
- IQVIA cash flow
- Thermo Fisher Scientific cash flow
- Icon PLC cash flow
- Agilent Technologies cash flow
- Avantor, Inc. cash flow
Head to head: DHR vs IQVDHR vs TMODHR vs ICLR
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies